A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Administration of the CD28 superagonistic antibody JJ316 is an efficient means to treat autoimmune diseases in rats, but the humanized antibody TGN1412 caused devastating side effects in healthy volunteers during a clinical trial. Here we show that JJ316 treatment of rats induced a dramatic redistribution of T lymphocytes from the periphery to the secondary lymphoid organs, resulting in severe T lymphopenia. Live imaging of secondary lymphoid organs revealed that JJ316 administration almost instantaneously (<2 minutes) arrested T cells in situ. This reduction in T cell motility was accompanied by profound cytoskeletal rearrangements and increased cell size. In addition, surface expression of lymphocyte function-associated antigen-1 was enhanced, endothelial differentiation sphingolipid G protein-coupled receptor 1 and L selectin levels were downregulated, and the cells lost their responsiveness to sphingosine 1-phosphate-directed migration. These proadhesive alterations were accompanied by signs of strong activation, including upregulation of CD25, CD69, CD134, and proinflammatory mediators. However, this did not lead to a cytokine storm similar to the clinical trial. While most of the early changes disappeared within 48 hours, we observed that CD4+CD25+FoxP3+ regulatory T cells experienced a second phase of activation, which resulted in massive cell enlargement, extensive polarization, and increased motility. These data suggest that CD28 superagonists elicit 2 qualitatively distinct waves of activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The first wave of T cell activation and redistribution was characterized by elevated levels of proinflammatory cytokines, including IL-17 and IFNγ as well as increased expression of the cell surface markers CD25, CD69, and CD134.”
From The calm after the cytokine storm: lessons from the TGN1412 trial (2008) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These authors found that i.v. infusion of rats with JJ316, the rat functional equivalent of TGN1412 that had been instrumental in most of the relevant preclinical studies, caused a rapid redistribution of all CD4 + T cells from the periphery to the spleen and lymph nodes (5), and therefore, simulated the T cell lymphopenia observed in humans following TGN1412 administration.”
From The calm after the cytokine storm: lessons from the TGN1412 trial (2008) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surprisingly, JJ316 infusion elicited only mildly elevated levels of TNFα and IFNγ in the serum of treated rats, which produced no discernable clinical effects and were several orders of magnitude below that seen in the TGN1412-treated subjects.”
From The calm after the cytokine storm: lessons from the TGN1412 trial (2008) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The authors showed, via intravital video microscopy, that T cell motility was dramatically reduced immediately following TGN1412 administration, suggesting that the observed T cell redistribution was a consequence of T cells becoming trapped in the secondary lymphoid organs.”
From The calm after the cytokine storm: lessons from the TGN1412 trial (2008) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In contrast, JJ316 treatment in the rats did not reproduce the massive cytokine storm observed following TGN1412 administration to the human volunteers.”
From The calm after the cytokine storm: lessons from the TGN1412 trial (2008) · cites this paper as [5]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Transmembrane crosstalk between the extracellular matrix and the cytoskeleton
Geiger, B., Bershadsky, A., Pankov, R., & Yamada, K. M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099066 · Cited by 2,209
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Mechanisms of suppression by suppressor T cells
von Boehmer, H. (2005) · Nature Immunology · doi:10.1038/ni1180 · Cited by 1,007
Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs
Cyster, J. G. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115628 · Cited by 856
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429
Self-citationRegulation of T-cell activation by the cytoskeleton
Billadeau, D. D., Nolz, J. C., & Gomez, T. S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2021 · Cited by 388
Alternative Vascularization Mechanisms in Cancer
Döme, B., Hendrix, M. J. C., Paku, S., Tóvári, J., & Tímár, J. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060302 · Cited by 359
Stebbings, R., Findlay, L., Edwards, C., Eastwood, D., Bird, C., North, D., Mistry, Y., Dilger, P., Liefooghe, E., Cludts, I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3325 · Cited by 316
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Riley, J. L., & June, C. H. (2005) · Blood · doi:10.1182/blood-2004-04-1596 · Cited by 315
Integrins and T Cell–Mediated Immunity
Pribila, J. T., Quale, A. C., Mueller, K. L., & Shimizu, Y. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104649 · Cited by 241
Down-regulation of homing receptors after T cell activation.
Jung, T. M., Gallatin, W. M., Weissman, I. L., & Dailey, M. O. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.12.4110 · Cited by 234
Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K. V., Lin, C.-H., Hanke, T., Hünig, T., Kerkau, T., & Gold, R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051060 · Cited by 203
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
Lin, C., & Hünig, T. (2003) · European Journal of Immunology · doi:10.1002/eji.200323570 · Cited by 184
Actin cytoskeletal dynamics in T lymphocyte activation and migration
Samstag, Y., Eibert, S. M., Klemke, M., & Wabnitz, G. H. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602272 · Cited by 176
Lymphocyte numbers and subsets in the human blood
Blum, K. S., & Pabst, R. (2007) · Immunology Letters · doi:10.1016/j.imlet.2006.10.009 · Cited by 170
Tacke, M., Hanke, G., Hanke, T., & Hünig, T. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270136 · Cited by 163
Flügel, A., Willem, M., Berkowicz, T., & Wekerle, H. (1999) · Nature Medicine · doi:10.1038/10567 · Cited by 156
Self-citationL-selectin in health and disease
Rainer, T. H. (2002) · Resuscitation · doi:10.1016/s0300-9572(01)00444-0 · Cited by 97
Tischner, D. (2006) · Brain · doi:10.1093/brain/awl213 · Cited by 82
Self-citationOdoardi, F., Kawakami, N., Li, Z., Cordiglieri, C., Streyl, K., Nosov, M., Klinkert, W. E. F., Ellwart, J. W., Bauer, J., Lassmann, H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608383104 · Cited by 52
Self-citationvan den Brandt, J., Lühder, F., McPherson, K., de Graaf, K. L., Tischner, D., Wiehr, S., Herrmann, T., Weissert, R., Gold, R., & Reichardt, H. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060804 · Cited by 48
Self-citationDennehy, K. M., Elias, F., Na, S.-Y., Fischer, K.-D., Hünig, T., & Lühder, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1363 · Cited by 45
Inhibition of Notch signaling biases rat thymocyte development towards the NK cell lineage
van den Brandt, J., Voß, K., Schott, M., Hünig, T., Wolfe, M. S., & Reichardt, H. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324735 · Cited by 37
Self-citationDennehy, K. M. (2003) · International Immunology · doi:10.1093/intimm/dxg063 · Cited by 36
Emerging therapeutic targets in multiple sclerosis
da Fontoura, P. P., Steinman, L., & Miller, A. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000227035.93199.e0 · Cited by 27
Sustained Pre-TCR Expression in Notch1IC-Transgenic Rats Impairs T Cell Maturation and Selection
van den Brandt, J., Kwon, S., Hünig, T., McPherson, K., & Reichardt, H. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7845 · Cited by 17
Self-citationLymphocyte Lineages at Mucosal Effector Sites: Rat Salivary Glands
O’Sullivan, N. L., Skandera, C. A., & Montgomery, P. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5522 · Cited by 15
Cited by
The safety and side effects of monoclonal antibodies
Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,144
Weirather, J., Hofmann, U. D. W., Beyersdorf, N., Ramos, G. C., Vogel, B., Frey, A., Ertl, G., Kerkau, T., & Frantz, S. (2014) · Circulation Research · doi:10.1161/circresaha.115.303895 · Cited by 699
Immunopathogenesis and treatment of cytokine storm in COVID-19
Kim, J. S., Lee, J. Y., Yang, J. W., Lee, K. H., Effenberger, M., Szpirt, W., Kronbichler, A., & Shin, J. I. (2021) · Theranostics · doi:10.7150/thno.49713 · Cited by 463
“anti-CD28 super-agonistic antibody, JJ316, to experimental rats and observed responses [19].”
BackgroundDelivering safer immunotherapies for cancer
Milling, L., Zhang, Y., & Irvine, D. J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.011 · Cited by 305
Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis
Kishore, M., Cheung, K. C. P., Fu, H., Bonacina, F., Wang, G., Coe, D., Ward, E. J., Colamatteo, A., Jangani, M., Baragetti, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.10.017 · Cited by 276
Metadata
- Authors
- Müller, N., van den Brandt, J., Odoardi, F., Tischner, D., Herath, J., Flügel, A., & Reichardt, H. M.
- Affiliations
- University of Würzburg (DE)
- Max Planck Society (DE)
- Corresponding author
- Reichardt, Holger M.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-04-01
- Volume
- 118
- Issue
- 4
- Pages
- 1405-1416
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2269726
- OpenAlex
- W2052306755
- Cited by
- 46
- References
- 30
- Citations by year
- 2024: 1 · 2023: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2017: 3 · 2016: 2 · 2014: 4 · 2013: 1 · 2012: 2
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Max Planck Digital Library (submittedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- Wilhelm Sander-Stiftung
- Deutsche Forschungsgemeinschaft (SFB455, 1.01.1/06/010)
- Georg-August-Universität Göttingen
- Gemeinnützige Hertie-Stiftung (1.01.1/06/010)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- T cell activation, T lymphopenia, T cell motility, CD11a/CD18, L-selectin, E-selectin, sphingosine-1-phosphate, regulatory T cells, Foxp3, T cell polarization, secondary lymphoid organs, T cell redistribution, autoimmune disease therapy, TGN1412, cytokine storm
- MeSH terms
- Animals, Antibodies, Cell Adhesion, Cell Movement, Cell Survival, Cytoskeleton, Lymphocyte Activation, Lymphoid Tissue, Lymphopenia, Male, Rats, Inbred Lew, T-Lymphocytes, Time Factors, Biomarkers, Up-Regulation, Cytokines, Cell Polarity, CD28 Antigens, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.